Theravance Biopharma
(NASDAQ) TBPH
Theravance Biopharma Financials at a Glance
Market Cap
$829.04M
Revenue (TTM)
$107.46M
Net Income (TTM)
$105.89M
EPS (TTM)
$2.03
P/E Ratio
7.94
Dividend
$0.00
Beta (Volatility)
0.63 (Low)
Dividend
$0.00
Beta (Volatility)
0.63 (Low)
Price
$16.50
Volume
16,034
Open
$16.05
Price
$16.50
Volume
16,034
Open
$16.05
Previous Close
$16.10
Daily Range
$16.03 - $16.52
52-Week Range
$8.09 - $21.03
Dividend
$0.00
Beta (Volatility)
0.63 (Low)
Price
$16.50
Volume
16,034
Open
$16.05
Previous Close
$16.10
Daily Range
$16.03 - $16.52
52-Week Range
$8.09 - $21.03
TBPH News
TBPH: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Theravance Biopharma
Industry
Pharmaceuticals
Sector
Health CareEmployees
90
CEO
Rick E. Winningham, MBA
Website
www.theravance.comHeadquarters
George Town, KY1-1104, KY
TBPH Financials
Key Financial Metrics (TTM)
Gross Margin
95%
Operating Margin
-12%
Net Income Margin
99%
Return on Equity
45%
Return on Capital
-3%
Return on Assets
22%
Earnings Yield
12.59%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$829.04M
Shares Outstanding
51.49M
Volume
16.03K
Short Interest
0.00%
Avg. Volume
627.85K
Financials (TTM)
Gross Profit
$101.95M
Operating Income
$13.25M
EBITDA
$7.73M
Operating Cash Flow
$238.54M
Capital Expenditure
$42.00K
Free Cash Flow
$238.50M
Cash & ST Invst.
$315.36M
Total Debt
$75.50M
Theravance Biopharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$45.89M
+144.7%
Gross Profit
$70.43M
+275.5%
Gross Margin
1.53%
N/A
Market Cap
$829.04M
N/A
Market Cap/Employee
$8.55M
N/A
Employees
97
N/A
Net Income
$61.02M
+493.0%
EBITDA
$19.07M
+350.9%
Quarterly Fundamentals
Net Cash
$239.86M
+522.5%
Accounts Receivable
$95.54M
+39.6%
Inventory
$0.00
N/A
Long Term Debt
$64.55M
+65.1%
Short Term Debt
$10.95M
+2.2%
Return on Assets
21.81%
N/A
Return on Invested Capital
-2.96%
N/A
Free Cash Flow
$6.07M
-456.0%
Operating Cash Flow
$6.06M
-572.3%